· · Ars Technica AI
FDA Panel Faces Criticism Over Peptide Drug Advocacy
Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.
#peptide drugs#fda panel#biotech#india pharmaceuticals#regulatory issues
Topic
#regulatory issues
1 article found